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Abstract
Background: Acute/subacute cerebral infarction (ASCI) in HIV-negative cryptococcal meningoencephalitis (CM)
adults has rarely been examined by a series of MRI-based follow-up study. We studied a series of MRI follow-up
study of CM adults and compared the clinical characters of those with ASCI and those without ASCI.
Methods: The clinical characteristics and a series of brain MRI findings of seven CM adults with ASCI were enrolled
for analysis. The clinical characteristics of another 30 HIV-negative CM adults who did not have ASCI were also
included for a comparative analysis.
Results: The seven HIV-negative CM adults with ASCI were four men and three women, aged 46-78 years. Lacunar
infarction was the type of ASCI, and 86% (6/7) of the ACSI were multiple infarctions distributed in both the anterior
and posterior cerebrovascular territories. The seven CM patients with ASCI were significantly older and had a
higher rate of DM and previous stroke than the other 30 CM adults without ASCI. They also had a higher incidence
of consciousness disturbance at presentation and had a poor prognosis.
Conclusion: ASCI was found in 18.9% (7/37) of HIV-negative CM adults. Serial MRI follow-up studies may allow a
better delineation of ASCI in this specific group of infectious disease and multiple lacunar infarctions was the most
common type. Older in age and presence of DM and previous stroke were the significant underlying conditions.
CM patients with ASCI also had a poor therapeutic outcome.
Background
Cryptococcal meningoencephalitis (CM) caused by
Cryptococcus neoformans infection is a serious central
nervous system (CNS) infection in immunocompro-
mised patients [1]. Among the immunocompromised
states, human immunodeficiency virus (HIV) infection is
an important one [1], but CM also occurs in individuals
with an apparently immunocompetent state [2-5].
Disturbed cerebral blood flow in the early stages of CM
has been noted [6], and the occurrence of cerebral
infarct may influence the therapeutic outcome [6,7].
There are case reports of cerebral infarction in CM
[8-12], but cranial magnetic resonance imaging (MRI)-
based assessment has been rarely examined solely.
Cerebrovascular diseases are also important neurologic
complications in HIV-infected patients [8,13], therefore,
the HIV-positive status may interfere with the interpre-
tation of the impact of CM on cerebrovascular disease.
For this consideration, we conducted an MRI-based
study to assess the clinical and neuroimaging features of
seven adult HIV-negative CM patients who had an
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stage of CM. For a clinical comparison, the clinical char-
acteristics of another 30 HIV-negative adults with CM
but without ASCI were also analyzed.
Methods
Over a period of seven years (2001-2007), 54 adult
patients aged >17 years at the Chang Gung Memorial
Hospital (CGMH)-Kaohsiung were retrospectively iden-
tified as having CM. Of these 54 CM adults, 37 had
been examined by brain MRI at admission. Of the 37
patients, seven were found to have ASCI. In the present
study, the clinical presentations, laboratory data, and
MRI findings of these seven patients were analyzed. The
clinical data of the other 30 CM adults who also under-
went brain MRI at admission but did not have ASCI
were included for a comparative analysis. This retro-
spective study was approved by the ethics committee of
Chang Gung Memorial Hospital (IRB 97-0467B).
In this study, CM was defined as in either of the fol-
lowing ways: (1) isolation of C. neoformans in one or
more cerebrospinal fluid (CSF) cultures, positive CSF
cryptococcal antigen (Ag) titer, or positive CSF India
ink staining and clinical features of meningitis; or (2) iso-
lation of C. neoformans in blood culture with clinical
presentations of meningitis and typical CSF features [5].
Cerebral ischemic stroke was defined according to the
WHO criteria [14], and cerebral infarction complicating
CM was defined as ASCI demonstrated by brain MRI at
admission for CM management. The MRI findings of
ASCI were defined as follows [15,16]: lesions with a
hyperintensity on diffusion-weighted images (DWIs) and
a hypointensity on apparent diffusion coefficient (ADC)
maps. Cerebral infarcts were classified as follows: lacu-
nar infarction vs. large infarction, anterior (territories of
anterior or middle cerebral arteries) vs. posterior (terri-
tories of vertebral, basilar, or posterior cerebral arteries)
and single vs. multiple infarctions (at least 2 regions of
infarction observed). Lacunar infarction (occlusion
of deep perforating arterioles) was defined as a subcorti-
cal, cerebellar, or brain stem infarction with a diameter
of <15 mm, and a large infarction (occlusion of large
intracranial arteries) was defined as a lesion of diameter
>15 mm. Brain MRI studies were performed on a 1.5T
scanner (Sigma Horizon; GE Medical Systems; Milwau-
kee, IL, USA) and included axial and sagittal T1- and
T2-weighted images. Gadolinium-DTPA was adminis-
tered to all the patients before the coronal and axial
T1-weighted images were captured. DWI (b-value =
1.000 s/mm
2) and ADC map capturing were similarly
performed. The methods involving the MR angiography
(MRA) technique in our study included 3-D TOF of
intracranial vessels and contrast MRA of neck vessels.
Maximum intensity projection (MIP) images were
reviewed on picture archiving and communication sys-
tem (PACS). MIP MRA images were evaluated for ste-
nosis, and the vascular distribution of lesions was
demonstrated [17]. In the meanwhile, all 37 CM patients
with ASCI received a series of chest x-ray and/or chest
computed tomography (CT) study to examine the pre-
sence of cryptococcoma or not. In the study period,
patients with CM were treated with given antifungal
drugs including amphotericin B ± fluconazole. The ther-
apeutic results of the included 37 CM pathients were
evaluated by using Glasgow Outcome Scale [18]: score
1 = death, score 2 = persistent vegetative state, score
3 = severe disability, score 4 = moderate disability,
score 5 = good recovery. The patients with a score of 1-
3 were classified as the group of poor prognosis, while
those with a score of 4 and 5, good prognosis.
For comparative analysis of the clinical and laboratory
characteristics of the CM patients with and without
ASCI, two separate statistical analyses were performed.
First, the age; CSF lactate, total protein, and glucose
levels; and WBC counts at the time of admission were
logarithmically transformed to improve normality and
were compared between the CM patients with and with-
out ASCI by using Student’s t-test. Data on clinical mani-
festations were compared between the two patient groups
by using the chi-square test or Fisher’s exact test. Second,
stepwise logistic regression was used to evaluate the rela-
tionship between significant univariables and the pre-
sence of ASCI, with adjustments made for potential
confounding factors. Variables with a zero cell count in a
2 × 2 table were eliminated from the logistic analysis, and
only variables with a strong association and statistical sig-
nificance (p < 0.05) were included in the final model. The
statistical tests were two-tailed and conducted using the
Statistical Analysis System software package, version 13.0
(2002; SAS Institute; Cary, NC, USA).
Results
The clinical characteristics and MRI findings of the
seven enrolled patients are listed in Tables 1 and 2. The
patients comprised four men and three women, aged
46-78 years (mean = 68.7 years). Underlying medical
conditions were found in all seven patients, and all had
altered consciousness as the clinical presentation at
admission. The other clinical manifestations were fever
in four patients, hemiparesis in four patients, seizure in
one patient, and oculomotor palsy in one patient. The
ASCI locations, MRA and other associated neuroima-
ging findings are presented in Table 1. Of the seven
patients, Case 5 had recurrent ASCI in the early stage of
CM, and his sequential MRI findings are shown in Fig-
ure 1. Pulmonary cryptococcoma was not found in the
seven CM patients with ASCI, but it was found in two
of the CM patients without ASCI.
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Page 2 of 7The therapeutic outcomes of the seven CM patients
with ASCI were that four patients (Cases 1, 2, 3, and 5)
s u r v i v e d ,w h i l et h r e e( C a s e s4 ,6 ,a n d7 )d i e d .C a s e s1
and 3 were bedridden, and Cases 2 and 5 were wheel-
chair bound. All these seven patients belonged to the
group of poor prognosis. As to the therapeutic results of
the other 30 CM patients without ASCI, 19 had a good
prognosis, while the other 11, a poor prognosis.
The comparative results of the seven patients with the
other 30 patients without ASCI are listed in Table 2,
and the significant findings were as follows: age at infec-
tion (p=0.033), altered consciousness on admission
(p=0.028), diabetes mellitus (DM) (p=0.037), previous
stroke (p=0.032), and poor prognosis (p = 0.003). The
variables used in the logistic regression included age at
infection and DM as the underlying conditions. After
analysis, only DM was found to be independently
associated with the presence of ASCI (p =0 . 0 2 6 ,O R=
10.5, 95%, CI = 1.32-83.49).
Discussion
The clinical presentations of CM are variable [1,19] and
the pathophysiology of its neurologic sequelae is also
complex [1,19]. Although many factors including posi-
tive cryptococcal antigenemia detection may influence
the appearance and presentations of clinical CM [20,21],
in patients with HIV-negative CM, little is known about
the duration between the contact with C. neoformans
and the occurrence of clinical symptoms as well as the
duration between the initial onset of symptoms and the
first consultation with a physician. In this study, all the
seven CM patients with ASCI had altered consciousness
and other focal neurologic signs for a varying period of
time (1 week-2 months) before they came to our
Table 1 Basic clinical data, findings of magnetic resonance imaging, and therapeutic outcome of the 7 HIV-negative
cryptococcal meningoencephalitis patients with acute/subacute cerebral infarctions
Case
No
Age
(y)/Sex
Clinical
presentations
(duration before
admission)
Underlying conditions Findings of magnetic resonance imaging Outcome
Sites of infarction MRA Others
1 70/M Headache, fever,
altered
consciousness,
right hemiparesis
(2 months)
Diabetes mellitus,
chronic renal disease
Bilateral thalami, rostrum of corpus
callosum
Mild
narrowing of
right MCA,
right PCA,
right ACA
- Survived
2 73/M Fever, altered
consciousness,
left hemiparesis
(1 month)
Previous stroke Pons: hemorrhage infarct, left
midbrain, right posterior limb
internal capsule
Narrowing of
left VA
Leptomeningeal
enhancement;
ventricular
dilatation, V-R space
dilatation
Survived
3 78/M Altered
consciousness,
fever, right
hemiparesis,
headache, seizure
(2 weeks)
Hepatitis C Splenium Narrowing of
right ACA,
MCA, ICA
V-R space dilatation Survived
4 46/F Altered
consciousness,
fever (2 months)
Hepatitis B, liver cirrhosis,
s/p liver transplantation
Right pons, right corona radiata,
cerebellum, bilateral temporal
region, bilateral basal ganglia,
bilateral high frontal, right occipital
Narrowing of
right VA
Leptomeningeal
enhancement,
ventricular
dilatation
Died
5 75/M Altered
consciousness
(1 week)
Diabetes mellitus 1
st: Right thalamus, left temporal
region; 2
nd: bilateral basal ganglion,
midbrain
Narrowing of
left ICA, right
ICA, left MCA,
right VA
- Survived
6 68/F Fever, altered
consciousness,
headache
(2 months)
Chronic renal disease,
hepatitis C, liver cirrhosis,
hepatocellular
carcinoma, previous
stroke
Midbrain, right temporoparietal
region
- Leptomeningeal
enhancement,
ventricular
dilatation
Died
7 71/F Fever, altered
consciousness,
right hemiparesis,
oculomotor palsy
(2 weeks)
Diabetes mellitus,
hypertension
Midbrain, bilateral thalami Poor
opacification
of bilateral
PCAs
Leptomeningeal
enhancement,
ventricular
dilatation, V-R space
dilatation
Died
M = male; F = female; y = years; VR = Virchow-Robin; MCA = middle cerebral artery; ACA = anterior cerebral artery; ICA = internal carotid artery; PCA = posterior
cerebral artery; VA = vertebral artery.
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Page 3 of 7hospital for treatment. As shown in this study, the initial
presentations of ASCI may be masked by or mixed with
other clinical features, but they were detected by an early
MRI study. CT study can show the various appearance of
intracranial cryptococcosis [22], but the superiority of
cranial MRI study to CT study in detecting the intracra-
nial lesions of CM has been well demonstrated in the
study of Charlier et al. [23]. Therefore, for thorough clini-
cal evaluation, early MRI study using specific imaging
sequences such as DWI and ADC maps should be man-
datory for early detection of ASCI in HIV-negative CM
patients.
It has been postulated that CM rarely results in cere-
bral infarction when compared with other fungal dis-
eases [24,25] and that cerebral infarction is common in
HIV-infected patients with CM [26,27], but these
assumptions were not based on a thorough MRI study.
Qureshi et al. [8] demonstrated an increased likelihood
of cerebral infarction in HIV-infected patients compared
with HIV-seronegative young individuals. Tjia et al. [28]
found a 4% incidence of cerebral infarction secondary to
CM in HIV-seronegative patients. In this MRI-based
study, ASCI was found in 18.9% (7/37) of the HIV-nega-
tive CM patients.
We examined the risks factors of ASCI in HIV-negative
CM patients, and the significant findings were as follows:
First, altered consciousness on admission and DM and
previous stroke as the underlying conditions are risk fac-
tors for ASCI. Second, a higher mean age at infection
was a risk factor associated with cerebral infarction in
HIV-negative CM patients. Therefore, in CM patients
with the above-mentioned significant factors, the clini-
cian should pay attention to the high possibility of ASIC
occurrence in this group of patients.
With serial transcranial color-coded sonography
(TCCS) and magnetic resonance angiography (MRA)
studies, cerebral hemodynamic change was found to be
last longer in CM than in acute bacterial meningitis
[6,29], but a mismatch of the findings between TCCS
and MRA studies in CM were also demonstrated [6].
Cerebrovascular complications are reported to be more
common in chronic meningitis than in promptly treated
acute symptomatic bacterial infections [29,30]. In the
seven cases of this study, MRI detected ASCI within
1 week to 2 months of the development of clinical
symptoms, and ASCI can recur during the therapeutic
course, as shown in Case 5. This finding regarding the
timing of the onset of ASCI is consistent with those
reported in the case of chronic meningitis [12,31,32],
which indicate that cerebral infarction can occur in both
the acute and late stages during treatment for chronic
meningitis.
There are several types of CM-related cerebrovascular
events reported in the literature [8-12,25,33]. This study
revealed that multiple cerebral infarctions were the most
common type (86%; 6/7; Cases 1, 2, and 4-7)), and sin-
gle infarction accounted for only 14% (1/7; Case 3).
With regard to the distribution of the cerebral infarc-
tions, both anterior and posterior cerebrovascular terri-
tories were involved in most patients. All the infarctions
were lacunar, and no large cerebral infarction was
noted. Hemorrhagic transformation was noted in only
one patient (Case 2). In chronic meningitis, the inflam-
matory reaction is most intense in the basal meninges
[6,12,34]. Because of this, basal exudates are usually
most severe at the circle of Willis, and most cerebral
infarcts are located in the territory of middle cerebral
artery (MCA), particularly in the territories of the med-
ial lenticulostriate and thalamoperforating arteries. In
one murine model study of CM conducted by Charlier
et al. [35], they showed that the primary event leading
to CM was the parenchyma invasion after crossing the
blood-brain-barrier at the cortical capillaries level
Table 2 Comparison of cryptococcal meningoencephalitis
patients with and without acute/subacute cerebral
infarction
Characteristics with ASCI
(n = 7)
without ASCI
(n = 30)
p-value
Median age; range (years) 71 (46-78) 55 (19-82) 0.033
*
Male 4 21 0.659
Female 3 9
Underlying conditions
Diabetes mellitus 3 2 0.037
*
Liver disease 3 3 0.068
Hypertension 1 6 1.000
Clinical manifestation
Fever 5 15 0.113
Altered consciousness 7 15 0.028
*
Seizure 1 6 1.000
Previous stroke 2 0 0.032
*
Hydrocephalus 4 11 0.408
Positive CSF India ink
staining
0 10/27 0.145
Positive CSF culture 4 20/28 0.652
CSF data median (range)*
WBC count (10
9/L) 144 (33-160) 136 (0-980) 0.575
Glucose level (mmol/L) 26.5 (14-53) 24 (0-255) 0.827
Glucose ratio 0.16 (0.07-0.31) 0.19 (0-0.96) 0.731
Total protein level
(g/L)
232.5 (113-431) 106 (55-1626) 0.131
Lactate level
(mmol/dL)
44.95 (31-67) 47.6 (9-97) 0.687
Cryptococcus antigen 1:384 (1:4-
1:1024)
1:1024 (1:4-
1:4096)
0.265
Prognosis
Poor 7 11 0.003
CSF = cerebrospinal fluid; WBC = white blood cell; * = p < 0.05.
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Page 4 of 7surrounded by the Virchow-Robin space which may
explain the high occurrence of brain lesions including
ischemic events in this territory. However, actually, the
stem and/or cortical branches of the MCA in the sylvian
fissure, the supraclinoid portion of the internal carotid
artery, and the vertebrobasilar system may also be
involved [36-38]. This pathophysiological characteristic
may explain why in our sevenC Mp a t i e n t s ,A S C Iw a s
widely distributed, and almost all cerebrovascular terri-
tories were involved. Brainstem and/or cerebellum invol-
vement were noted in 57% (4/7) of the HIV-negative
CM adults with ASCI; this relatively high incidence of
posterior fossa involvement in previously reported stu-
dies [8,9,12,13] were not MRI-based study. MRA for our
seven CM cases showed varying degrees of arterial ste-
nosis. Many mechanisms have been proposed for the
cerebral vasculopathy in CM, including strangulation of
vessels at the skull base, vasculitis, spasm, contraction,
and thrombotic occlusion [6,9,39].
The therapeutic results of these seven patients showed
a mortality rate of 43% (3/7), and all the survivors had
serious neurologic deficits. This result is consistent with
the previous belief that CM is a serious infectious
disease of the CNS [1-3]. The CM patients with ASCI
had a significant incidence of altered consciousness, as
s h o w ni nT a b l e2 ,a tt h ee a r l ys t a g eo fC Ma n dh a da
poor prognosis of statistical significance when compared
with those CM patients without ASCI. The prognostic
influence of cerebral infarction on patients with chronic
meningitis was also mentioned before [12].
Conclusion
18.9% of adult HIV-negative CM patients have ASCI in
the early stage of the disease. Multiple lacunar infarc-
tions involving all cerebrovascular territories are com-
mon stroke features in this specific group of CNS
infection, and most of the involved individuals are old
and have other medical risk factors, such as DM and
p r e v i o u ss t r o k e ,f o rA S C I .O u rH I V - n e g a t i v eC M
patients with ASCI also had a higher incidence of
altered consciousness in the early stage of the disease
and had a poor therapeutic outcome.
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Figure 1 Brain magnetic resonance imaging (MRI) (diffusion-weighted images (1a-1f) and corresponding apparent diffusion coefficient
maps (1h-1m)) and MR angiographic (1g and 1n) studies of Case 5. Figures 1a, 1b, 1h, and 1i (captured at the time of admission) show
acute/subacute infarctions at the right thalamus (arrow) and left temporal region (arrowhead). Figure 1g (captured at the time of admission)
shows suspected stenosis of the left internal carotid artery (arrow). Figures 1c-1f and 1j-1m (captured on the 17
th day after admission) show new
infarctions in the midbrain (arrow), bilateral basal ganglia (arrowhead), and corpus callosum (arrows). Figure 1n (captured on the 17
th day after
admission) shows multiple cerebral arterial stenoses (arrow).
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